Hirtle Callaghan & Co’s SEQUENOM INC NEW SQNM Stock Holding History

Hirtle Callaghan & Co’s Portfolio SQNM Stock Details SQNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,000	Closed	-$7K	–	458
2014 Q4	$7K	Hold	2,000	–	–	﹤0.01%	453
2014 Q3	$6K	Hold	2,000	–	–	﹤0.01%	500
2014 Q2	$8K	Hold	2,000	–	–	﹤0.01%	519
2014 Q1	$5K	Hold	2,000	–	–	﹤0.01%	528
2013 Q4	$5K	Hold	2,000	–	–	﹤0.01%	506
2013 Q3	$5K	Buy	+2,000	New	+$6.72K	﹤0.01%	518

Other funds holding SQNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hirtle Callaghan & Co's SQNM Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of SEQUENOM INC NEW (SQNM) in Q1 2015, closing a stake of 2,000 shares — an estimated $7K sold.

Hirtle Callaghan & Co first reported a position in SQNM in Q3 2013 and held it in 6 quarters. The position peaked at $8K in Q2 2014. 120 funds tracked by Wall St. Rank hold SQNM as of Q1 2015.

Hirtle Callaghan & Co reported no remaining SEQUENOM INC NEW position as of Q1 2015 after selling out during the quarter.
Hirtle Callaghan & Co sold 2,000 SEQUENOM INC NEW shares in Q1 2015, an estimated $7K.
Hirtle Callaghan & Co first reported a position in SEQUENOM INC NEW in Q3 2013 and held it in 6 quarters.
Hirtle Callaghan & Co's SEQUENOM INC NEW position peaked at $8K in Q2 2014.
120 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.